Adaptive Biotechnologies GAAP EPS of $0.06 beats by $0.20, revenue of $93.97M beats by $29.32M
Source: SeekingAlpha
2025-11-05 16:39:58 ET
More on Adaptive Biotechnologies
- Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade)
- Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Adaptive Biotechnologies Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Adaptive Biotechnologies
- Historical earnings data for Adaptive Biotechnologies
Read the full article on Seeking Alpha
For further details see:
Adaptive Biotechnologies GAAP EPS of $0.06 beats by $0.20, revenue of $93.97M beats by $29.32M
Adaptive Biotechnologies Corporation
NASDAQ: ADPT
ADPT Trading
3.65% G/L:
$12.915 Last:
1,468,501 Volume:
$13.05 Open:
ADPT Latest News
February 05, 2026 04:05:00 pm
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
January 22, 2026 04:05:00 pm
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
ADPT Stock Data
$2,393,790,148
142,894,616
2.45%
99
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
